You've used all available free searches this month | for more free features.
Clincosm LogoSign in Get a demo

Myopia prevention and control

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myopia Trial in Shanghai (Shorter-wavelength dominant light, Light similar to the solar spectrum proportion, Longer-wavelength

Recruiting
  • Myopia
  • Shorter-wavelength dominant light
  • +2 more
  • Shanghai, Shanghai, China
  • +1 more
Oct 25, 2022

Myopia Trial in Shanghai (1% atropine 5+3)

Recruiting
  • Myopia
  • 1% atropine 5+3
  • Shanghai, Shanghai, China
    Shanghai Eye Diseases Prevention & Treatment Center
Jul 11, 2022

Myopia, Progressive, Myopia Trial in Singapore (Test myopia control lenses, Single vision lenses)

Active, not recruiting
  • Myopia, Progressive
  • Myopia
  • Test myopia control lenses
  • Single vision lenses
  • Singapore, Singapore
    Essilor R&D Centre Singapore
Nov 3, 2022

Obesity, Myopia Trial (Multidimensional non-drug instrumental intervention)

Not yet recruiting
  • Obesity
  • Myopia
  • Multidimensional non-drug instrumental intervention
  • (no location specified)
Mar 23, 2022

Myopia, Progressive Trial in Xuzhou (PBM, Peripheral defocus spectacles, Single vision spectacles)

Recruiting
  • Myopia, Progressive
  • PBM
  • +2 more
  • Xuzhou, Jiangsu, China
    the first people's hospital of Xuzhou
Mar 7, 2023

Myopia Trial in Yuexiu, Nankai (Novel spectacle lens, Single vision spectacle lens)

Not yet recruiting
  • Myopia
  • Novel spectacle lens
  • Single vision spectacle lens
  • Yuexiu, Guangzhou, China
  • +1 more
May 23, 2023

Myopia, Myopia Progression, Juvenile Myopia Trial in United States (Spectacle Lenses)

Not yet recruiting
  • Myopia
  • +2 more
  • Spectacle Lenses
  • Whittier, California
  • +8 more
May 30, 2023

Myopia, Progressive Trial in Tianjin (Single vision lens, +2D PDL, +3D PDL)

Active, not recruiting
  • Myopia, Progressive
  • Single vision lens
  • +3 more
  • Tianjin, China
    Tianjin Eye Hospital
May 9, 2022

Myopia Trial in Singapore (Test myopia control lenses (BSL))

Recruiting
  • Myopia
  • Test myopia control lenses (BSL)
  • Singapore, Singapore
    Essilor R&D Centre Singapore
Sep 8, 2022

Myopia Trial in San Francisco (Low-level Red Light Therapy Device)

Active, not recruiting
  • Myopia
  • Low-level Red Light Therapy Device
  • San Francisco, California
    University of California, San Francisco
Nov 2, 2022

Myopia, Progressive Trial in Shanghai (Airdoc Red Lighting Device, Special Spectacles to Control Myopia)

Recruiting
  • Myopia, Progressive
  • Airdoc Red Lighting Device
  • Special Spectacles to Control Myopia
  • Shanghai, China
    Shanghai Children Medical Center
May 21, 2023

High Myopia, Refractive Errors, Eye Diseases Trial in Shanghai (RLRL)

Not yet recruiting
  • High Myopia
  • +2 more
  • RLRL
  • Shanghai, Shanghai, China
    Shanghai Eye Disease Prevention and Treatment Center
Oct 17, 2022

Myopia Trial in Rishon LeZion (Lenses)

Active, not recruiting
  • Myopia
  • Lenses
  • Rishon LeZion, Israel
    "Maor" Institute Clinic
Jul 28, 2022

Myopia Trial in Australia, United States (Vivior)

Not yet recruiting
  • Myopia
  • Vivior
  • Berkeley, California
  • +4 more
Nov 3, 2023

Myopia Trial in Tianjin (Defocus Distributed Multi-point lens, Single vision lens)

Active, not recruiting
  • Myopia
  • Defocus Distributed Multi-point lens
  • Single vision lens
  • Tianjin, China
    Tianjin Eye Hospital
Dec 5, 2022

Myopia, Progressive Trial in San Antonio (Proclear Single Vision Contact Lenses manufactured by CooperVision, Proclear

Withdrawn
  • Myopia, Progressive
  • Proclear Single Vision Contact Lenses manufactured by CooperVision
  • Proclear Multifocal Contact Lenses manufactured by CooperVision
  • San Antonio, Texas
    Bowden Eye Care & Health Center
Jul 3, 2022

Myopia, Progressive Trial in Waterloo (Novel spectacle lens design)

Active, not recruiting
  • Myopia, Progressive
  • Novel spectacle lens design
  • Waterloo, Ontario, Canada
    Centre for Ocular Research and Education
Nov 3, 2022

Myopia Trial in Beijing, Shanghai (low-dose atropine eye drops, orthokeratology)

Recruiting
  • Myopia
  • low-dose atropine eye drops
  • orthokeratology
  • Beijing, Beijing, China
  • +1 more
Jul 26, 2022

Myopic Progression Trial in Kowloon (orthokeratology, Menicon Progent A+B)

Active, not recruiting
  • Myopic Progression
  • orthokeratology
  • Menicon Progent A+B
  • Kowloon, Hong Kong
    School of Optometry, The Hong Kong Polytechnic University
Jul 18, 2022

Children Under Myopia Control Treatment (Pilot Study)

Completed
  • Accomodation
  • +2 more
  • Auditory biofeedback traing
  • Long Beach, New York
    State University of New York, College of Optometry
Jan 1, 2023

Deep Learning-based Myopia and Myopic Maculopathy Detection and

Completed
  • Myopia
  • Myopic Macular Degeneration
  • A deep learning-based myopia and myopic maculopathy detection and prediction system
  • Shanghai, Shanghai, China
    Shanghai Eye Disease Prevention and Treatment Center
Apr 18, 2023

Myopia Trial in Paris (Defocus Incorporated Multiple Segments® (DIMS®) lenses, Atropine 0.05% eyedrops, Monofocal lenses)

Recruiting
  • Myopia
  • Defocus Incorporated Multiple Segments® (DIMS®) lenses
  • +2 more
  • Paris, France
    Hôpital Fondation Adolphe de Rothschild
Dec 7, 2022

Myopia Trial in Columbus, Houston (Contact lenses)

Active, not recruiting
  • Myopia
  • Contact lenses
  • Columbus, Ohio
  • +1 more
May 13, 2022

Myopia Trial in Holon (Myolens CN (Central-Near) soft contact lens, MiSight® soft contact lens)

Recruiting
  • Myopia
  • Myolens CN (Central-Near) soft contact lens
  • MiSight® soft contact lens
  • Holon, Israel
    Wolfson Medical Center
Jun 27, 2022

Myopia, Juvenile Myopia, Myopia Progression Trial in United States (Single vision, impact-resistant spectacle lenses; Test Arm,

Not yet recruiting
  • Myopia
  • +2 more
  • Single vision, impact-resistant spectacle lenses; Test Arm
  • Single vision, impact-resistant spectacle lenses; Control Arm
  • Raytown, Missouri
  • +3 more
Sep 5, 2023